A group of attorneys is suing the company that marketed remdesivir as a safe and effective drug, which many hospitals administered to COVID-19 patients and whose efficacy has been called into question.
Jamie Scher is one of those attorneys, and she joined Liz Collin this week to discuss the class action lawsuit filed in California.